Carlo Presutti
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (2)
Background We investigated the role of Nuclear Receptor Binding SET Domain Protein 2 (NSD2) and microRNAs (miRNAs) in melanoma de‐differentiation following Romidepsin and Interferon‐α2b (RI) treatment. Melanoma is the most lethal form of skin cancer, and despite advancements in therapy, treatment resistance remains a major challenge. De‐differentiation has been widely recognized as a key factor contributing to therapy resistance. Methods RNA‐seq and TCGA transcriptomic data were re‐analyzed to identify miRNAs and NSD2 expressions. The functional impact of selected miRNAs was then investigated at the molecular and phenotypic levels using primary and immortalized cell lines. Results Our findings demonstrate that RI treatment induces a de‐differentiation process in primary melanoma cells, resembling that observed in therapy‐resistant melanoma. This effect is particularly pronounced in cells with an intrinsic proliferative phenotype, where we observed significant downregulation of NSD2, a key epigenetic regulator implicated in multiple cancers. Additionally, we identified specific miRNAs as mediators of NSD2 downregulation, influencing melanoma cell viability and fitness. Conclusions These findings provide new insights into the molecular mechanisms driving melanoma progression and highlight potential therapeutic targets to counteract treatment resistance.
Year:
2025
Year:
2024
Collaborators (3)
Elvira De Leonibus
Professor in Charge
University of Rome Tor Vergata
Andrea MELE
Full professor, Psychobiology
Sapienza University of Rome
Giulia Torromino
RTT
Sapienza University of Rome
Make your next move.
Prepare your application
Review drafts before you send them.